Search Within

Michel W J Sadelain

Formats
  1. Meeting Abstract (289)
  2. Journal Article (277)
  3. Review (5)
  4. Editorial (4)
  5. Conference Paper (3)
  6. Research Letter (3)
  7. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (583)
  2. Department of Medicine (583)
  3. GSK Faculty (583)
  4. Hematologic Malignancies Research (583)
  5. Hematologic Malignancies, Division of (583)
  6. Molecular Pharmacology and Chemistry Program Faculty (583)

More Groups

People
  1. Isabelle Riviere (200)
  2. Renier Brentjens (116)
  3. Xiuyan Wang (91)
  4. Jae Park (82)
  5. Jorge Mansilla-Soto (43)
  6. Kevin Curran (36)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (21)
  4. 2022 (18)
  5. 2021 (23)
  6. 2020 (16)

More Years

Publications
  1. Blood (133)
  2. Molecular Therapy (56)
  3. Cancer Research (24)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Blood Cells, Molecules, and Diseases (12)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. Nature Publishing Group (125)
  3. Elsevier Inc. (49)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (19)
  6. Cell Press (16)

More Publishers

Results (583)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Research Letter

    Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease
    Meeting Abstract

    Boulad, F.; Zhang, J.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease
    Meeting Abstract

    Avecilla, S.; Boulad, F.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease
    Journal Article

    Avecilla, S. T.; Boulad, F.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • CAR T cells: Building on the CD19 paradigm
    Review

    Globerson Levin, A.; Rivière, I.; Eshhar, Z.; Sadelain, M.
    European Journal of Immunology (2021)

    Fulltext@MSK | Save
  • Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
    Journal Article

    Zhang, M.; Zhao, Z.; Pritykin, Y.; Hannum, M.; Scott, A. C.; Kuo, F.; Sanghvi, V.; Chan, T. A.; Seshan, V.; Wendel, H. G.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Emergence of a hyper-proliferative phenotype in TET2 edited human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save